Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 05, 2023 15:18 ET | Source: Robbins LLP

Infinity Pharmaceuticals, Inc. Investors: Lead Plaintiff Deadline is Approaching in the Class Action Against Infinity Pharmaceuticals, Inc.; Contact Robbins LLP Today

Infinity Pharmaceuticals, Inc. (INFI) Misled Investors Regarding its Business Prospects
September 29, 2023 14:22 ET | Source: Robbins LLP

Lead Plaintiff Deadline Approaching: Infinity Pharmaceuticals, Inc. Investors Should Contact Robbins LLP for Information About the Infinity Pharmaceuticals, Inc. Class Action

Infinity Pharmaceuticals, Inc. (INFI) Misled Investors Regarding its Business Prospects
September 06, 2023 17:26 ET | Source: Robbins LLP

INFI Stockholders Should Contact Robbins LLP for Information About the Class Action Involving Infinity Pharmaceuticals, Inc.

SAN DIEGO, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of persons and entities that purchased or otherwise acquired Infinity...
August 28, 2023 17:03 ET | Source: Robbins LLP

INFI Stock News: Investors with Significant Losses in Infinity Pharmaceuticals, Inc. Should Contact Robbins LLP About Recovery

SAN DIEGO, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of persons and entities that purchased or otherwise acquired Infinity...
August 21, 2023 12:35 ET | Source: Robbins LLP

Infinity Pharmaceuticals, Inc. (INFI) Shareholder Notice: Robbins LLP Reminds Investors of Class Action Filed Against Infinity Pharmaceuticals, Inc.

SAN DIEGO, Aug. 21, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of persons and entities that purchased or otherwise acquired Infinity...